PD-1 signaling and PD-1 blockade–mediated tumor control are established at microvillar T cell contacts

View at publisher
Authors: Edward Jenkins, Martin Fellermeyer, Daniel F. Heraghty, Sumana Sharma, Tanmay Mitra, Mateusz Kotowski, J Clarke, Yuan Lui, Sam Daly, Zach Marin, Debasis Banik, Markus Körbel
+7 more Emily Zhi Qing Ng, Thomas Lister, Ana Mafalda Santos, Steven F. Lee, Michael Dustin, Simon J. Davis, David Klenerman
Cited by: 1
References: 83

Abstract

Lymphocyte activation relies on the integration of signals from multiple receptors at cell-cell contacts, but the spatiotemporal regulation of this process is unclear. Here, we show that programmed cell death protein 1 (PD-1) and T cell receptor (TCR) signals are integrated at nanoscale microvillar close contacts formed during T cell interactions with their targets. PD-1 signaling begins as these contacts form and selectively limits the duration, but not the amplitude, of TCR signaling. PD-1 suppresses TCR activity directly, by locally recruiting Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP2), and indirectly, by reducing cell-spreading, close-contact formation, and TCR engagement. A PD-1 blocking antibody induced inhibitory signaling when Fc receptor engagement trapped PD-1 at close contacts. Engineering the antibody to prevent PD-1 trapping eliminated these agonistic effects and improved blockade efficacy. These findings identify microvillar contacts as crucial hubs of initial signal integration and provide a framework for optimizing checkpoint immunotherapies.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Monoclonal and Polyclonal Antibodies Research

Publication details

Journal / source
Science Immunology
Publisher
American Association for the Advancement of Science (AAAS)
Volume
11
Issue
119
Pages
eadz4983–eadz4983
Publication date
15 May 2026
Language
EN